(VIANEWS) – The NASDAQ ended the session with 10x Genomics (TXG) jumping 4.32% to $160.74 on Tuesday while NASDAQ Composite rose 0.71% to $15,129.09.
Today’s last reported volume for 10x Genomics is 540648, 11% below its average volume of 607529.
10x Genomics’s last close was $154.09, 26.27% under its 52-week high of $208.99.
10x Genomics’s Sales
10x Genomics’s sales growth is 78.1% for the ongoing quarter and 33.2% for the next. The company’s growth estimates for the current quarter and the next is 70.8% and 97.2%, respectively.
10x Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
10x Genomics’s stock is considered to be overbought (>=80).
10x Genomics’s Stock Yearly Top and Bottom Value
10x Genomics’s stock is valued at $160.74 at 17:36 EST, way under its 52-week high of $208.99 and way higher than its 52-week low of $125.84.
10x Genomics’s Moving Average
10x Genomics’s value is under its 50-day moving average of $162.38 and under its 200-day moving average of $174.64.
More news about 10x Genomics (TXG).